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Abstract
Multi-walled carbon nanotubes (MWCNTs) are increasingly used in industry and in nanomedicine 
raising safety concerns, especially during unique life-stages such as pregnancy. We hypothesized 
that MWCNT exposure during pregnancy will increase vascular tissue contractile responses by 
increasing Rho kinase signaling. Pregnant (17–19 gestational days) and non-pregnant Sprague 
Dawley rats were exposed to 100 μg/kg of MWCNTs by intratracheal instillation or intravenous 
administration. Vasoactive responses of uterine, mesenteric, aortic and umbilical vessels were 
studied 24 hours post-exposure by wire myography. The contractile responses of the vessel 
segments were different between the pregnant and non-pregnant rats, following MWCNT 
exposure. Maximum stress generation in the uterine artery segments from the pregnant rats 
following pulmonary MWCNT exposure was increased in response to angiotensin II by 4.9 
mN/mm2 (+118%), as compared to the naïve response and by 2.6 mN/mm2 (+40.7%) as compared 
to the vehicle exposed group. Following MWCNT exposure, serotonin induced approximately 4 
mN/mm2 increase in stress generation of the mesenteric artery from both pregnant and non-
pregnant rats as compared to the vehicle response. A significant contribution of the dispersion 
medium was identified as inducing changes in the contractile properties following both pulmonary 
and intravenous exposure to MWCNTs. Wire myographic studies in the presence of a Rho kinase 
inhibitor and RhoA and Rho kinase mRNA/protein expression of rat aortic endothelial cells were 
unaltered following exposure to MWCNTs, suggesting absent/minimal contribution of Rho kinase 
to the enhanced contractile responses following MWCNT exposure. The reactivity of the umbilical 
vein was not changed; however, mean fetal weight gain was reduced with dispersion media and 
MWCNT exposure by both routes. These results suggest a susceptibility of the vasculature during 
gestation to MWCNT and their dispersion media-induced vasoconstriction, predisposing reduced 
fetal growth during pregnancy.
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Introduction
An increasing number of single- and multi-walled carbon nanotubes (SWCNTs and 
MWCNTs) are being designed and produced for various industrial and biomedical 
applications such as tracers of malignant cells, immunomodulators, contrast agents and as 
scaffolds in tissue engineering [1,2]. Pulmonary exposure to MWCNTs are reported to be 
associated with adverse effects similar to asbestos exposure [3] involving impairment in 
pulmonary functions [4] and activation of inflammatory responses in mesothelial cells [5]. 
MWCNTs are known to be taken-up by bronchial epithelial cells, increase pro-inflammatory 
cytokine production and induce cytotoxicity in in vitro studies [6,7]. When considering their 
bio-distribution, MWCNTs translocate to the lymph nodes following intratracheal 
instillation [8,9] and potentially to other extra-pulmonary organs including the liver, kidney 
and heart and contributing to various toxico-pathologies [10]. The extra-pulmonary effects 
of MWCNT exposure is reported to be associated with impairment of endothelium 
dependent relaxation in coronary arterioles [11] and increased coronary vascular tone 
enhancing indices of ischemia reperfusion injury [12]. The adverse pulmonary effects 
following occupational exposure to carbon nanotubes have been studied extensively in non-
pregnant animal models [9,13]. The consequences of MWCNT exposure on the peripheral 
vascular system are yet to be studied adequately, particularly in the unique physiological 
stage of pregnancy.
In general, exposure to MWCNTs occurs by inhalation during occupational exposures in 
industry or in research laboratories [13–15]. Potential biomedical applications could also 
expose an individual to MWCNTs primarily by the intravenous route [16]. An animal model 
study on MWCNT exposure during pregnancy reported minimal effects on fetal 
development and maternal well-being following oral exposure to 8–1000 mg/kg/day of 
MWCNTs [17]. The expansive vascular remodeling that takes place during pregnancy 
[18,19] may predispose the maternal and fetal vasculature to be sensitive to nanomaterial 
exposures by various routes (i.e. pulmonary and intravenous) where increased concentrations 
of MWCNTs may directly reach the circulation. The consequence of any changes in 
vascular reactivity can potentially negatively influence the placental blood supply, impacting 
fetal growth and development. Following acute intravenous exposure, pristine carbon 
nanotubes are redistributed to the reticulo-endothelial system [16,20] with a significant 
proportion remaining in blood [21]. This is in contrast to functionalized forms, which are 
reported to be excreted unchanged via the kidney [22,23]. It can be assumed that these 
nanotubes come in direct contact with the vascular endothelium during their circulation and 
these interactions can potentially induce changes in vascular reactivity during pregnancy by 
various mechanisms.
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Multiple vasoconstrictor agents including phenylephrine, endothelin 1, angiotensin II and 
serotonin act through Gq protein coupled receptors to regulate smooth muscle contraction in 
the vasculature. Downstream of this receptor, the RhoA/Rho kinase pathway plays a critical 
role in mediating contractile response in vascular smooth muscle cells. The active form of 
RhoA promotes activation of the Rho kinase (ROCK) that inhibits MLC phosphatase 
(MLCP) activity, the dephosphorylation of myosin and subsequent relaxation [24]. 
Alterations in the RhoA/Rho kinase pathway is reported to be involved in endothelial 
dysfunction, inflammation [25,26] and with exposure to particulate matter [27].
We hypothesized that MWCNT exposure during pregnancy would increase the contractile 
responses in uterine and placenta derived blood vessels by increasing the RhoA/Rho kinase 
activity. We also hypothesized that there will be differential effects on the contractile 
responses dependent on the route of exposure and the vascular bed location. Intratracheal 
instillation and intravenous administration were used as the two routes of exposure to 
identify these differential effects within thoracic aorta, mesenteric and uterine arterial 
segments.
Methods and Materials
MWCNT suspensions for exposure
Multi-walled carbon nanotubes (MWCNTs) were a generous gift from NanoTechLabs Inc. 
(Yadkinville, NC, USA) and the dry powder form was previously characterized [4]. The 
commercial grade, non-functionalized, hydrophobic carbon based nanotubes were 
suspended in non-polar solvents/dispersion media prior to in vivo exposure. MWCNTs for 
intratracheal instillation was suspended in 10% clinical grade surfactant (Infasurf®, ONY, 
Inc., Amherst, NY, USA), to mimic protein-lipid coating from lung surfactant, in sterile 
0.9% saline (0.9% NaCl, B. Braun Medical Inc., CA, USA) as previously described [4] to a 
concentration of 150 μg/ml and the mixture was cup-horn sonicated for 2 minutes at 65% 
amplitude for a total energy of 10,817 Joules, using a Misonix ultrasonic liquid processor 
-1510R-MTH (Branson Ultrasonics Corp. Danbury, CT, USA). This suspension will be 
referred to as “(S)-MWCNTs” and had been previously characterized by Wang et al. [4]. 
Additionally, the MWCNTs were suspended in the dispersion media modified from Bihari et 
al. [28] for intravenous administration to coat with a vascular compartment protein. Briefly, 
this dispersion media contained 0.6mg/ml rat serum albumin (Sigma, A6272), 0.01 mg/ml 1, 
2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, Sigma F-0763) in phosphate buffered 
saline (Sigma D5652 1X) and sonicated using the probe sonicator at 40% amplitude for 15 
seconds. This dispersion medium will be referred to as “DPPC/RSA”. A MWCNT 
suspension of 150 μg/ml was made with DPPC/RSA and the mixture was cup-horn 
sonicated using a Misonix ultrasonic liquid processor -1510R-MTH (Branson Ultrasonics 
Corp. Danbury, CT, USA) at 65% amplitude for 2 minutes. This intravenous suspension will 
be referred to as “(D)-MWCNTs” and was previously described by Wang et al. [29].
Sprague Dawley rats
Pregnant and non-pregnant female, 10–12 week old Sprague Dawley rats were purchased 
from Charles River Laboratories (USA). All rats were acclimated for one week in East 
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Carolina University (ECU) Department of Comparative Medicine’s animal facility, housed 
under 12 hour light/dark cycles with standard rat chow and water provided ad libitum. The 
pregnant rat arrived in the facility between 9–12 days of gestation and the body weight was 
monitored once in every three days to assess the progression of pregnancy. All animal 
handling and exposure procedures were approved by the ECU Institutional Animal Care and 
Use Committee.
MWCNT exposure and dosing
Each pregnant and non-pregnant female rat was randomly assigned to either the MWCNT 
exposure or dispersion medium control group for each route of exposure to include a 
minimum of six animals in a group. Matched gestational day pregnancies were used to 
compare vehicle vs. MWCNT effects. The pregnant rats were exposed between 17–19 days 
of gestation, compatible with the third trimester of human pregnancy (i.e. late gestational 
stage). Rats were anesthetized using 2–3% isoflurane (Webster Veterinary, USA) dispersed 
in oxygen for exposure procedures. The 150 μg/ml MWCNT suspension was administered 
as a mass based dose of 100 μg/kg by weighing each rat just before the exposure. (S)-
MWCNTs suspension or 10% surfactant was instilled intratracheally (IT) as previously 
described [4,12] for pulmonary exposure. A group of non-pregnant female rats was exposed 
to IT (S)-MWCNTs or 10% surfactant to evaluate any effect of life stage (pregnant vs. non-
pregnant) on vascular tissue contractility. Intravenous (IV) administration of 100 μg/kg (D)-
MWCNTs or DPPC/RSA was done in the pregnant rats through the tail vein using a 25G 
needle. Ten to twelve weeks old, pregnant (GD 17–19) and non-pregnant female rats were 
used as naïve controls.
Tissue and sample collection
All rats were anesthetized in a transparent sealed receptacle containing gauze soaked with 
70% isoflurane (Webster Veterinary, USA) in propylene glycol (Amersco, OH, USA), 
separated from the animal by a desiccator plate/grid prior to euthanasia. Twenty-four hours 
following administration of the MWCNTs or vehicle, the rats were subjected to a midline 
incision and euthanized by pneumothorax. Whole blood (~1 ml) was withdrawn directly 
from the maternal right ventricle. A pooled fetal blood sample was collected from three 
fetuses in each pregnant dam (blood from these three fetuses were considered as one 
sample). Maternal and fetal whole blood samples were centrifuged (20,400 × g for 20 
minutes), and serum supernatant was stored at −80°C for cytokine analysis.
Isolation of vessel segments
Three arterial beds and the umbilical vein were selected for pharmacological myographic 
studies. The uterine and mesenteric vascular beds were selected as they manifest both 
structural and functional changes during pregnancy [30,31] with the uterine vasculature 
undergoing significant remodeling [32]. The thoracic aorta was included as proximal conduit 
vessel not anticipated to undergo significant remodeling, but still may express changes in 
pharmacological responses. Both uterine horns with the vascular arcades, small intestinal 
loop with superior mesenteric arcade and thoracic aorta were carefully excised and placed in 
ice cold physiological saline solution (PSS; mM) 140 NaCl, 5.0 KCl, 1.6 CaCl2, 1.2 MgSO4, 
1.2 MOPS (3-[N-morpholino]-propane sulfonic acid), 6 D-glucose, 0.02 EDTA, and a pH of 
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7.4). Arterial segments with a length of 0.5 – 2.0 mm were isolated from the mid region of 
the main uterine artery (diameter 150–300 μm), first order mesenteric artery (diameter 150–
250 μm), and thoracic aorta (diameter 2–3 mm). Two umbilical vein segments (diameter 
400–550 μm) from umbilical cords of different fetuses implanted in the mid-uterine region 
were isolated from each dam.
Maternal and fetal serum cytokine analysis
The targets for maternal and fetal serum cytokine analysis were selected based on the 
reported cytokine targets in previous MWCNT exposure studies [4,33,34]. The selected 
serum cytokines and chemokines (IL6, IL10, TNFα, MCP1, VEGF, INFγ, and IL1β) were 
assessed using Milliplex MAP Cytokine/Chemokine Panel and Immunoassay (EMD 
Millipore MA, USA) according to the manufacturer’s directions. Assays were run using 
Luminex 100/200 (Luminex, Austin, TX) and results reported using Luminex xPONENT® 
software versions 2.3/3.1.
Bronchoalveolar lavage cytology
Twenty-four hours following exposure to MWCNTs or dispersion media, a bronchoalveolar 
lavage (BAL) was performed on adult female rats as described previously [4]. Briefly, the 
right lung was lavaged in situ three times with repeated flushes of 26.25 mL/kg body weight 
of ice-cold Hanks balanced salt solution. The BAL fluids were centrifuged and the total 
number of cells was calculated using an automated cell counter (Cellometer, Nexcelom 
Bioscience, and Lawrence, MA, USA). A sample of 20,000 cells was centrifuged using a 
Cytospin IV (Shandon Scientific Ltd., Cheshire, UK) and stained with a three-step 
hematology stain (Richard Allan Scientific, Kalamazoo, MI, USA). The differential cell 
count was determined by morphology, evaluating 300 cells per slide using light microscopy 
and each cell count is reported as a percentage of 20,000 cells.
Wire myographic studies
The dissected vessel segments were mounted into a DMT 610M multi-channel wire 
myograph system (Danish Myo Technology, Aarhus N, Denmark) using 40 μm wires or 
pins. All vessel segments were bathed in PSS at 37°C, bubbled with medical grade air 
during the entire myographic studies. The optimal resting tension for each arterial segment 
was established at 90% of internal circumference (IC) produced at tensions equivalent to 100 
mmHg (13.3 kPa). A depolarization response with K+PSS (109 mM K+ equal molar 
substitution of Na+) was used to assess the vessel viability and segments that developed a 
stress response of greater than 1 mN/mm2 were considered viable. Endothelial viability was 
assessed by adding 3.0 μM acetylcholine during a 1 μM phenylephrine pre-contraction. Each 
segment along the arterial tree adapts to different hemodynamic conditions including blood 
pressure and autonomic innervations. Such adaptations will express different receptor 
classes and relative amounts of their subtypes, thus it is necessary to investigate different 
agonist responses in different vascular segments. All three arterial (uterine, mesenteric and 
aortic) vessel segments were subjected to cumulative concentrations of phenylephrine 
(0.001–30 μM), endothelin-1 (0.0001–1 μM) and acetylcholine (0.0001–30 μM). 
Angiotensin II (0.0001–0.1 μM) and serotonin (0.001–1 μM) was used to study the uterine 
and mesenteric arteries respectively. The force generated by each vessel segment at each 
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concentration was recorded using Lab Chart (ADI Instruments, CO, USA). The force was 
then normalized to the surface area of the vessel to determine the active stress generated in 
response to different agonists.
The umbilical vein segments were stretched and set to an IC equal to 90% of the IC when 
the wall tension is equivalent to 20 mmHg (5.1 kPa) [35]. The viability was assessed using 
K+PSS. The segments were pre-contracted with thromboxane-mimetic U46619 (1 μM) and 
subjected to cumulative concentrations of acetylcholine (0.0001–30 μM), followed by 1 μM 
sodium nitroprusside.
Cell culture, mRNA and protein quantification
Rat aortic endothelial cells (RAEC) in the in vitro studies were used to identify the 
contribution of the endothelial RhoA/Rho kinase signaling following direct exposure to 
MWCNTs suspended in different media. RAEC were purchased from Cascade Biologics 
(Eugene, OR, USA), grown with Dulbecco’s Modified Eagle Medium (DMEM) and 
cultured at >90% confluence were treated with (S)-MWCNTs or (D)-MWCNTs over a 1–10 
μg/cm2 dose range for 2–12 hours. Untreated cells, 10% surfactant treated cells and 
DPPC/RSA treated cells were used as controls. Real time-PCR was done as described 
previously [24] to identify any changes RhoA, ROCK1, ROCK2 and eNOS mRNA 
expression following 2 hours of exposure to MWCNTs. Following 12-hour in vitro exposure 
to MWCNTs or dispersion medium, In-Cell Western Assay (Li-Cor Biosciences, Lincoln, 
NE, USA) was performed to assess the changes in target protein expression [25] for RhoA, 
ROCK1, ROCK2 and eNOS. The cell media was removed and the cells were immediately 
fixed with 3% formaldehyde followed by permeabilization with 0.1% Triton-X, blocked 
with Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE, USA). The primary 
antibodies for RhoA (1:1000), ROCK1 (1:500), ROCK2 (1:500) and eNOS (1:1000) (Santa 
Cruz Biotechnology Inc., USA and Cell Signaling Danvers, MA, USA) were added and 
plate incubated overnight. IRDye 800CW Secondary Antibodies (LI-COR Biosciences, 
Lincoln, NE, USA) were used in 1:10000 dilutions to identify target proteins. The DNA was 
stained with DRAQ5 and Sapphire 700 (Cell Signaling, Danvers, MA, USA) for cell number 
normalization. The Fluorescence was detected, quantified and analyzed using Li-Cor 
Odyssey Infrared Imaging System and software (LI-COR Biosciences, Lincoln, NE, USA).
Measurement of the fetal and placental weight
Body weights of pregnant dams were recorded just before sacrifice and the litter size was 
recorded before uterine vessel isolation. Three fetuses were isolated from each dam from the 
mid-uterine region and individual weights were measured using Ohaus Explorer Analytical 
Balance (Ohaus Corporation, NJ, USA). The blot weights of the placentae attached to the 
same fetuses were also recorded. The individual weights of the fetuses/placentae were then 
grouped according to the day of gestation at sacrifice and their mean weight was used for 
comparison between the treatment groups. Each day of gestation included the pups from at 
least 2 dams.
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Statistical analysis was done utilizing GraphPad Prism 5 software (San Diego, CA) and data 
is presented as mean ± SEM (standard error of mean). Repeated measures analysis of 
variance [36] and Bonferroni post hoc test were used to compare the concentration-
responses of different agonists and the differences were considered statistically significant if 
p<0.05. In addition, each concentration-response curve was also compared across treatment 
groups using a regression analysis by examining the best-fit values [36]. EC50 values for 
concentration-responses in myographic studies were determined using the Hill equation. A 
two tailed t test was used compare mean EC50, umbilical vein stress generation, and 
cytokine expression levels between different treatment and control groups. One way 
ANOVA and Turkey post-hoc test was used for the analysis of fetal and placental weight on 
each day of gestation.
Results
Characterization of MWCNT suspensions
The MWCNT suspension in 10% surfactant in saline [(S)-MWCNTs] has been previously 
characterized by Wang et al. [4]. MWCNTs used in this study had a mean diameter of 22.5 
± 1.3 nm with a bimodal distribution with peaks at 12.5 and 25 nm and a length range of 10–
100 μm and a surface area of 113.1 m2/g). The zeta potential of the particles in (S)-
MWCNTs suspension was −57.3 mV with a mean hydrodynamic size of 915 nm. MWCNTs 
suspended in the DPPC, serum albumin and sterile phosphate buffered saline medium [(D)-
MWCNTs] was characterized previously by Wang et al. [29] with a zeta potential of −20.8 
mV with a mean hydrodynamic size of 793 nm.
Maternal serum cytokine analysis
The mean values serum cytokine levels of pregnant and non-pregnant rats 24 hours 
following exposure to MWCNTs or dispersion media for each route of exposure are reported 
in Table 1. The baseline cytokine levels in the naïve rats were relatively higher in the non-
pregnant group compared to the pregnant group for all cytokines assessed except VEGF. In 
general, the cytokine profiles for the rats exposed to vehicle or MWCNT were lower in the 
non-pregnant group while a few changes were noted in the pregnant group. IL1β level was 
increased by five fold in the pregnant group (when compared to the naive) following IV 
DPPC/RSA. TNFα levels were increased more than six fold in the serum following exposure 
to both dispersion media (10% surfactant and DPPC/RSA) and increased with IV (D)-
MWCNTs.
Maternal Bronchoalveolar Lavage (BAL) cell counts
The percentages of differential cell counts in the bronchoalveolar lavage fluid are graphed in 
Supplementary Figure 1 and MWCNT induced changes in these cell counts were observed 
only in the pregnant group. The mean percentage of macrophages was 4.2% lower in the 
naïve pregnant group compared to the naïve non-pregnant group, and increased during 
pregnancy following exposure to both vehicles (by 4.8% with 10% surfactant and by 5.0% 
with DPPC/RSA) and intravenous (D)-MWCNT exposure (by 4.3%) compared to the naive. 
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In contrast, the mean epithelial cell percentage was 4% higher in the naïve pregnant group 
compared to the naïve non-pregnant group and was reduced by ~5% during pregnancy by 
following exposure to both vehicles and MWCNTs by both routes of exposure when 
compared to the naive. The percentage of neutrophils were highest following exposure to 
(S)-MWCNTs via intratracheal instillation but was less than 1% of the total BAL cell 
counts. The percentages of eosinophils were not significantly different following exposure to 
MWCNTs during pregnancy.
Responses of arterial segments 24 hours post-exposure to intratracheal (IT) instillation of 
(S)-MWCNTs or 10% surfactant in pregnant and non-pregnant female rats
The contractile responses of the vessel segments from the pregnant and non-pregnant rats 
were different following IT exposure to (S)-MWCNTs. In general, the pregnant group 
manifested increased contractile responses in multiple vascular beds that were in part 
contributed to by the dispersal media as opposed to minimal changes in observed in the non-
pregnant group.
Main uterine artery
The main uterine artery segments from pregnant and non-pregnant rats responded differently 
to the same dose of IT instilled (S)-MWCNTs. The maximum stress generation was 
increased in the pregnant group in response to phenylephrine by 2.6 mN/mm2 (+37%) 
following IT exposure to (S)-MWCNTs when compared to the naïve, but was not 
significantly increased when compared to the responses from 10% surfactant group (Figure 
1A). The response to angiotensin II following IT exposure to (S)-MWCNT during 
pregnancy was increased by 4.9 mN/mm2 (+118%), as compared to the naïve and by 2.6 
mN/mm2 (+40.7%) as compared to the 10% surfactant exposed group (Figure 1B). In 
contrast, the stress generation in response to all 3 agonists was diminished in uterine artery 
segments from non-pregnant animals following (S)-MWCNTs exposure (Figure 1B, D and 
F). The relaxation responses to acetylcholine during 30 μM phenylephrine pre-contraction 
were not different in naive, 10% surfactant and (S)-MWCNTs exposed pregnant groups 
(Figure 1G), but was diminished ~ 10% following (S)-MWCNTs exposure in the non-
pregnant group (Figure 1H). The calculated EC50 values for phenylephrine, angiotensin II, 
acetylcholine and HA-1077 were not different between the naive, 10% surfactant and (S)-
MWCNTs treatment groups. Following (S)-MWCNTs exposure in pregnant rats, calculated 
EC50 value for endothelin 1 (1.1 ± 0.3 nM) was significantly lower than the naive (3.4 ± 0.6 
nM), but not different form the 10% surfactant exposed group (2.2 ± 1.0 nM, Supplementary 
Table 1).
First order mesenteric artery
The mesenteric artery segments from both pregnant and non-pregnant rats responded in a 
similar manner following IT (S)-MWCNT exposure. The stress generations in response to 
serotonin in the first order mesenteric artery segments were increased by ~ 4 mN/mm2 
following IT (S)-MWCNTs exposure compared to 10% surfactant exposed group (Figure 2E 
and F). The contractile responses to phenylephrine or endothelin 1 and the relaxation 
response to acetylcholine were not changed following IT (S)-MWCNT exposure in the 
pregnant group (Figure 2A, C and G).
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The mesenteric artery contractile responses to all 3 agonists were diminished in the non-
pregnant rats exposed to 10% surfactant (Figure 2B, D and F), along with an impairment of 
acetylcholine dependent relaxation response (Figure 2H). Similar to the reported uterine 
vessels responses, the EC50 values of the mesenteric arteries responses following (S)-
MWCNT exposure were not different except for endothelin 1 (Supplementary Table 2). The 
EC50 for endothelin 1-mediated responses was decreased in the 10% surfactant (1.4 ± 0.4 
nM) group when compared to both naïve (5.4 ± 1.3 nM) and (S)-MWCNTs exposed group 
(5.0 ± 1.0 nM).
Thoracic aorta
The thoracic aortic segments from pregnant and non-pregnant rats responded differently to 
the IT exposure to (S)-MWCNTs. The contractile response to phenylephrine (0.001–10 μM) 
was reduced by 0.68 mN/mm2 (25.4%) in the pregnant group following (S)-MWCNT 
exposure compared to the naïve, but was not different when compared to the 10% surfactant 
exposed group (Figure 3A). The contractile response to endothelin 1 from the pregnant 
thoracic aorta segments was increased in both (S)-MWCNTs and 10% surfactant exposed 
groups when compared to the naïve. There was a noticeable relaxation response to highest 
concentration of endothelin 1 in the (S)-MWCNT exposed pregnant group (Figure 3C). In 
contrast, the contractile responses to phenylephrine and endothelin 1 were not affected by 
(S)-MWCNT or 10% surfactant exposure in the non-pregnant female rats (Figure 3B and D).
The acetylcholine (0.001–10 μM) mediated relaxation response was not different in the 
pregnant group (Figure 3E), but was increased in both (S)-MWCNTs and 10% surfactant 
exposed non-pregnant aortic segments when compared to the naïve (Figure 3F). The EC50 
values were not different for the contractile and relaxation responses following (S)-MWCNT 
exposure (Supplementary Table 3).
Responses of arterial segments 24 hours post-exposure to intravenous (IV) administration 
(D)-MWCNTs or DPPC/RSA in pregnant rats
Twenty four hours following IV administration in pregnant rats, both (D)-MWCNTs and 
DPPC/RSA increased the maximal stress generation in the main uterine artery segments to a 
similar magnitude (3 – 4 mN/mm2) when compared to naïve vessel segments with a similar 
concentration-response profile for the agonists: phenylephrine, endothelin 1 and angiotensin 
II (Figure 4A–C). The DPPC/RSA exposure elevated the baseline stress level of the uterine 
vessel segments while the (D)-MWCNTs exposure had no additional effect. The relaxation 
responses of the main uterine artery to acetylcholine were not changed by IV (D)-MWCNT 
or DPPC/RSA exposure (Figure 4D). We did not proceed to do non-pregnant comparisons in 
this exposure group as the differences in the contractile responses were attributed sole to 
DPPC/RSA suspension and not to MWCNT exposure.
An increase in contractile response in the mesenteric artery segments was seen at higher 
concentrations of phenylephrine following (D)-MWCNT exposure (supplementary Figure 
2A). All other contractile/relaxation responses of the mesenteric artery and aortic segments 
were not significantly different between the (D)-MWCNTs or DPPC/RSA exposure groups 
(supplementary Figures 2B–D and 3A–C). Unlike in the uterine artery, DPPC/RSA did not 
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have a significant effect on the baseline stress level of the mesenteric artery or thoracic aorta. 
The EC50 values for all responses are reported in supplementary Tables 1–3 and were not 
different with the exception for endothelin 1, where the EC50 was reduced in the in the 
thoracic aortic segments following (D)-MWCNTs (13.3 ± 5.1 nM) or DPPC/RSA (12.4 
± 5.1 nM) exposure when compared to the naïve (71.9 ± 17.8 nM, Supplementary Table 3).
Contribution of Rho kinase activity on the vascular tissue contractility following exposure 
to MWCNTs
Maintenance of stress in the presence of Rho kinase inhibitor—Minor 
differences were observed in the relaxation responses to cumulative concentrations of the 
Rho kinase (ROCK) inhibitor, HA1077, during the stable phenylephrine pre-contraction for 
segments from all three vascular beds, regardless of the pregnancy state or route of exposure 
to the MWCNT (Figure 5 and Supplementary Figure 4). The EC50 values for the 
concentration responses are reported in Supplementary Tables 1–3 and were not significantly 
different following MWCNT exposure except within the IV (D)-MWCNT exposure group 
during pregnancy (2.6 ± 0.2 μM compared to 1.8 ± 0.3 μM in the DPPC/RSA exposed 
group).
RhoA, ROCK and eNOS mRNA and protein expression in rat aortic endothelial 
cells—The mRNA expression of RhoA, ROCK1, ROCK2 and eNOS was not significantly 
changed in RAEC with 2–12 hour treatment with (S)-MWCNTs or (D)-MWCNTs when 
compared to untreated cells and vehicle controls (data not shown). Similarly, the protein 
expression of RhoA, ROCK and eNOS were not changed with 12 hours in vitro exposure to 
10 μg/cm2 of (S)-MWCNTs or (D)-MWCNTs as assessed by the In-cell Western Assay 
(Supplementary Figures 5 and 6).
Changes in the fetal components following MWCNT exposure
Changes in umbilical vein contractility—The reactivity of the umbilical vein (vessel 
from the placenta to the fetus) was assessed following both IT and IV administration. Stress 
generation during K+PSS and 1 μM of thromboxane mimetic (U46619) stimulations were 
not significantly different in umbilical vessel segments between MWCNT exposed (by either 
exposure route) and naïve animals (Figure 6A–D). The umbilical vein segments did not 
respond to acetylcholine and the relaxation response to 1μM sodium nitroprusside with a 
stable U46619 pre-contraction was not different following MWCNT exposure (Figure 6E 
and F).
Changes in fetal and placental weight—Mean weights of pregnant dams at the time 
of sacrifice were not significantly different between treatment groups (mean ± SEM): (S)-
MWCNTs 298.2 ± 12.0 g (n=6), 10% surfactant 291.0 ± 10.8 g (n=6), (D)-MWCNTs 305.8 
± 7.8 g (n=6), DPPC/RSA 333.4 ± 24.9 g (n=6), and naïve 287.2 ± 10.9 g (n=10). The mean 
and range of litter size were also not different between the exposure groups: (S)-MWCNTs 
10.7 (8–13), 10% surfactant 10.5 (10–11), (D)-MWCNTs 9.8 (9–11), DPPC/RSA 10.5 (9–
12) and naïve 10.6 (8–13). Mean weights of the fetuses are reported in Figure 7A and B, 
after grouping them according to gestational day (GD). The mean fetal weight was reduced 
at GD 19 following MWCNT and dispersion media exposure by both routes and was evident 
Vidanapathirana et al. Page 10













across all gestational days studied following intravenous exposure. Gross external 
morphological abnormalities were not seen in the fetuses. An increase in the mean placental 
weight was observed following MWCNT exposure by both routes on GD 18 (Figure 7C and 
D).
Fetal serum cytokine analysis
The cytokines levels in the fetal serum were not significantly changed following exposure to 
MWCNT or dispersion media by either route of administration and are reported in Table 2.
Discussion
Twenty hours post exposure to MWCNT by either intratracheal or intravenous 
administration resulted in a limited alteration in isolated blood vessel segments’ responses to 
various pharmacological agents. The intratracheal instillation of 100 μg/kg of (S)-MWCNTs, 
was of note for we observed an increase in the contractile response to angiotensin II in the 
main uterine artery when compared to the response from the non-pregnant state. This 
increase in of stress generation of the uterine artery following MWCNT exposure was 
confined to the late gestational stage. Minimal changes in the contractile responses due to 
MWCNT exposure were seen in vessel segments from the other vascular beds studied in 
both pregnant and non-pregnant state. The enhanced contractile responses were not 
associated with comparable changes in relaxation responses with Rho kinase inhibition, 
suggesting that mechanisms other than RhoA/Rho kinase may underlie alterations in 
contractile responses. To our knowledge, this is one of the first attempts to identify 
pregnancy related changes in the contractile responses of several vascular tissues following 
exposure to MWCNTs by different routes.
The physiochemical characteristics of the suspensions of the MWCNTs are important in 
understating any delivery characteristics. According to Henderson et al, the pulmonary 
responses are similar in response to particle exposure by either inhalation or instillation, 
provided similar lung burdens [37]. Intratracheal instillation has been suggested to deliver 
less well dispersed MWCNTs to the lung epithelium resulting in fewer adverse effects when 
compared to short term inhalational exposure [34,38]. On the other hand, instillation exposes 
the animal to an acute, higher concentration of nanoparticles compared to inhalational 
exposure over a long period [34], bypassing the nasal cavity. Accounting for these 
conditions, the results from our IT exposure might be used to speculate on the outcomes of 
long term inhalational exposure. Exposure levels have been identified in laboratory and 
industrial facilities [15] handling MWCNTs. Current proposed guidelines by the National 
Institute for Occupational Safety and Health (NIOSH) limits nanotube exposure to 7 μg/m3 
[39] and a human occupational exposure of 5 mg/m3 during a 8-hour day and 40-hour work 
week equate to approximately 20 μg of SWCNT aspiration in a mouse model [40]. A recent 
publication by Erdely et al. [41] identified a mean airborne mass concentration of 10.6 
μg/m3 MWCNTs across eight different facilities that handle carbon nanotubes in the United 
States, which was calculated to correspond with a human alveolar deposition of 4.07 μg/day 
[41]. In a study designed to mimic such conditions while weighing and moving dry 
materials, MWCNT were found to range from 4,514–123,403 particles/L of air [42]. 
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Considering that average tidal volume in humans is 500 mL of air and average respiration 
rate is 12 breaths a minute (i.e. with a resting respiratory minute volume of 5 L/min), 
humans breathe approximately 360 L air/hour on average, this could result in a deposition of 
1,625,040 – 44,425,080 MWCNT particles into the lungs in 1 hour. Based on calculations 
from flow-cytometry data (not shown), a 100 μg MWCNT exposure mass translated to 
approximately 743,000 particles per rat. Employing these most recent occupational exposure 
values (10.6 μg/m3 [41]) it would require between 3–107 hours of constant occupational 
exposure to achieve a similar dosing used in our studies. Considering these conditions, and 
compared to other inhalational/instillation studies [13], 100 μg/kg dose used in the current 
study is a moderate - high dose. We choose to use an equivalent dose of MWCNTs in our IV 
exposure model to identify any effects of exposure to the same mass based dose of 
MWCNTs by two different routes. Future dose response studies including both low and high 
levels of exposure during pregnancy may be beneficial before applying these findings for 
regulatory purposes.
Previous studies with inhalational exposure to MWCNTs for 24–168 hours have identified a 
maximal impairment of endothelium dependent relaxation in coronary arterioles at 24 hours 
[11]. Therefore, the 24-hour post-exposure time point in this study should be conducive to 
identify changes in the contractile responses in extra-pulmonary vascular beds. Even during 
intravenous exposure, MWCNTs redistribute mainly to the lung and liver tissues [43] as 
pulmonary and hepatic circulations may be functioning as a filters during the first pass 
metabolism. The pulmonary responses to MWCNT deposition in such circumstances may be 
initiating the inflammatory cascade, contributing to changes in the contractile responses.
Several factors including the properties of MWCNT suspensions, route of exposure, 
pulmonary/systemic inflammatory response, pregnancy related physiological changes and 
sensitivity of the vascular bed may contribute to the differential contractile responses of 
vascular tissues that we have observed in this study. The reported zeta potentials of (S)-
MWCNTs and (D)-MWCNTs suggest that both suspensions have a relatively good stability 
with minor agglomerate formation. The minor differences in the hydrodynamic size and zeta 
potential in different suspensions may not alone contribute significantly to modification of 
the vessel behavior via MWCNT exposure, as seen in different routes of exposure.
Previously reported distribution of MWCNTs following intravenous administration suggests 
that majority of the particles are distributed in the lungs following their first pass in 
circulation [23]. On the other hand, these particles are primarily distributed in the lungs 
following intratracheal instillation/pulmonary exposure [44]. Considering these distribution 
patterns by both routes, we chose to study the immune mediated pulmonary responses by 
analyzing the cell counts in a broncoalveolar lavage. We report a pregnancy related increase 
in the BAL cell counts suggesting an inflammatory response, reported as higher percentages 
of macrophages with both dispersion media and (D)-MWCNTs and the increased 
neutrophils with (S)-MWCNT exposure. Comparable changes in neutrophil and eosinophil 
counts were seen with pulmonary exposure to increasing doses of (S)-MWCNTs in a male 
mouse model [4]. These pulmonary responses following exposure to dispersion media or 
MWCNTs are also compatible with changes in the cytokine profiles, increased vascular 
tissue contractility and reduction in the fetal weight gain. The changes in the maternal serum 
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cytokine levels reported in our study does not indicate any preferential immune response as 
IFNγ (Th1), IL6 and IL10 (Th2) levels are not affected following exposure to MWCNTs by 
either route of administration. The increase in TNFα levels appears to be robustly influenced 
by both dispersant media (10% surfactant and DPPC/RSA) rather than MWCNTs and may 
potentially induce a Th1 type response, which can be detrimental during pregnancy (36). 
This conclusion is also supported by the reduction in fetal weight seen with both (D)-
MWCNTs and DPPC/RSA. An increase in IL1β level was seen with both 10% surfactant 
and DPPC/RSA suggesting an immunological response to both dispersion media, which was 
down-regulated by the addition of MWCNTs. Previous studies have reported both Th1 and 
Th2 type immune responses following acute exposure to MWCNTs with increased levels of: 
TNFα, IL1β, IL6, IL10, and MCP1 (33, 38) early after exposure and reported to wane over 
time (39), supporting the low levels we measured at 24 hours post-exposure.
The overall stress generation in segments of the main uterine artery, from the naïve pregnant 
rats was lower compared to the response from naive non-pregnant rats, a response reflecting 
normal vasodilatory vascular behavior associated with pregnancy [18,19]. However, the 
uterine artery did present with an augmented response to Angiotensin II. Angiotensin II 
mediated responses are altered in the uterine vasculature during adverse pregnancy states 
such as pre-eclempsia where the AT1 receptor mediated constrictor function of angiotensin 
II predominates over the AT2 receptor mediated vasodilatory function [45,46]. The increased 
in contractility observed in the gestational uterine artery segments in our study could be 
mediated by alteration of either/both AT1 and AT2 receptor function following MWCNT 
exposure. Additionally, the calculated EC50 values for endothelin 1 were different in 
segments from all three vessels studied, suggesting an altered sensitivity to endothelin 1 or 
changes in endothelin receptor distribution with pregnancy. In contrast to the non-pregnant 
group, a significant increase in the contractile responses was evident only with the pregnant 
uterine artery segments, following (S)-MWCNT exposure. These observations suggest that 
pregnancy may render the uterine vasculature more susceptible to MWCNT exposure 
induced changes in contractility. Therefore, our observation of an increase in the contractile 
response or shifts in EC50 values following (S)-MWCNT exposure suggests there may be an 
adverse pregnancy outcome following pulmonary MWCNT exposure during pregnancy.
Compared to the uterine vasculature, the overall stress generation of mesenteric artery and 
thoracic aortic segments in response to contractile stimulation were not significantly 
different between naïve pregnant and non-pregnant animals. This relationship was not 
altered following MWCNT exposure by either route. The only difference in responses was 
observed at higher concentration of serotonin in the mesenteric artery, where we observed a 
higher stress generation/lower relaxation response following (S)-MWCNT exposure that 
could be mediated by alteration in the serotonin receptor profiles following MWCNT 
exposure. We interpret the contrast in response of the vessels from the different vascular 
beds to be related to the limited extent of remodeling that occurs in the mesenteric artery and 
thoracic aorta with pregnancy and renders them less vulnerable to the influence of MWCNT 
exposure.
The alterations in contractile responses reported in this study (in response to angiotensin II 
and serotonin) are similar to the potentiation of stress generation reported with other 
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cardiovascular pathologies, linked with elements of calcium sensitization and regulation of 
the contractions by RhoA/Rho kinase pathway [47,48]. As reported in Figure 5 and 
Supplementary Figure 4, there were only minor differences in the sensitivity to Rho kinase 
inhibition in all three vascular beds following exposure to MWCNTs or dispersion media by 
either route of exposure. Thus a response compatible with action of Rho kinase as being 
responsible for the augmented contractile responses was not evident with MWCNT 
exposure. Additionally, the lack of changes in Rho associated proteins and eNOS in rat 
aortic endothelial cells exposed to MWCNTs in vitro would suggest that this pathway is not 
mediating changes in the endothelial cell contribution to the augmented stress through 
regulation of eNOS as reviewed by Yao et al. [25] and Satoh et al. [48]. Thus in aggregate 
these data suggest that the rho kinase signaling was not a primary mechanism responsible 
for augmented stress generation observed following MWCNT exposure. Other mechanisms 
postulated to enhance force generation can include generation of reactive oxygen species 
[49], increased oxidative stress [50] and enhanced cyclooxygenase signaling [51]. SWCNTs 
have shown to increase oxidative stress and alter the mitochondrial signaling following 
intrapharyngeal instillation [52]. MWCNTs may also affect the cardiovascular functions by 
comparable mechanisms but have yet to be fully investigated.
Previous in vitro studies including proteomics analysis have shown that cellular functions 
and pathways comprising generalized gene transcription and protein translation are affected 
by direct exposure to MWCNTs [33,53]. Alternatively, the changes in the vascular system 
may be mediated through bronchial epithelial cell release of pro-inflammatory cytokines 
into circulation, such as IL6 and IL8 [6]. MWCNTs can also translocate following 
pulmonary exposure via instillation and reach the extra-pulmonary sites [8,54], including the 
vasculature leading to a local inflammatory response. Our previous in vitro studies done 
with human aortic endothelial cells indicate increased expression of endothelial 
inflammatory markers following exposure to (S)-MWCNTs [33] and may support a 
mechanism for cytokine production which can influence vascular tissues.
When trying to understand the IT exposed MWCNT induced changes, it is important to 
recognize that 10% surfactant used as a vehicle for suspending the MWCNTs also induces a 
notable increase in stress generation in response to agonist stimulation compared the 
constrictive responses from naïve animal group. We suggest that (S)-MWCNTs may have a 
combined effect of both MWCNTs and surfactant and this effect is clearly demonstrated in 
response to angiotensin II in the main uterine artery segments during pregnancy. However, 
synthetic lung surfactant based suspensions are established for studying pulmonary exposure 
effects of MWCNTs [55] and we chose to use the same for our study and were surprised to 
see such a vascular response effect. The responses seen with intravenous exposure to 
MWCNTs appear to be due to properties of the dispersant medium rather than due to 
nanotubes as DPPC/RSA significantly increases the baseline stress generation. The different 
media for the two routes of exposure were selected to simulate the biological media that area 
related to the exposure routes and were speculated to have no/minimal effects on vascular 
contractile responses. The dispersant medium is known to affect the cellular uptake of the 
nanoparticles [56] and presumed to impact overall cellular function. The dispersant media 
are known to contribute to the composition of protein or lipid corona associated with the 
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nanoparticles in the biological systems [57,58]. It may be likely that the corona on these 
MWCNT is different enough to mask a significant MWCNT effect.
Neither MWCNTs nor dispersion medium induced significant changes in contractile 
responses of umbilical vein segments, suggesting that these exposures may only be affecting 
the maternal side of the circulation. However, detrimental effects were seen in the mean fetal 
weight following MWCNT exposure via both routes along with a significant contribution by 
the dispersion media alone. The IV exposure to (D)-MWCNTs appeared to be more effective 
at reducing the fetal growth earlier in gestational exposure window studied, whereas the 
weight reduction following IT exposure is mainly attributed to dispersion media. The 
placental transfer of the nanoparticles is affected by multiple factors including the particle 
size, dispersion medium, and the stage of the pregnancy [59] which could contribute to 
effects on fetal growth. Additionally, fetal microvessel dysfunction following exposure to 
engineered nanomaterials which was recently proposed by Stapleton et al. [11] may be a 
possible underlying explanation for our observations of reduced fetal weight despite the 
absence of augmented contractile responses in umbilical circulation. Stapleton et al. [11] 
used the fetal tail artery as a representative vessel from the fetal microcirculation and 
reported decreased responses in both endothelium dependent and independent relaxation 
[60]. Their findings suggests the applicability of the Barker Hypothesis (i.e. the relation 
between retarded growth in early life and risk of adult disease is due to long term effects on 
physiology and metabolism imposed by an adverse environment during critical periods of 
development) to explain the changes observed in the fetus following maternal nanoparticle 
exposure [60,61]. This hypothesis may also hold true for our MWCNT exposure scenario, 
suggesting that the differences in the fetal weight gain may be a reflection of limited blood 
supply due to increased contraction observed in the uterine vascular segments.
Conclusions
In conclusion, the observations in this study suggest that vascular contractility may change 
following MWCNT exposure depending on multiple factors, including life stage (pregnant 
or non-pregnant), route of exposure, MWCNT dispersion media and the target vascular bed. 
Multiple agonist-mediated responses are differentially affected between the pregnant and 
non-pregnant stages with a significant increase in the stress generation of the uterine artery 
in response to angiotensin II confined to the pregnant stage. These agonists alter the 
contractile mechanism through various signaling cascades and we assessed the contribution 
RhoA/Rho kinase pathway in mediating these responses. We were unable to demonstrate 
that the RhoA/Rho kinase signaling cascade was significantly altered in response to 
MWCNT exposure and could not account for the augmented contractile responses, 
suggesting that other pro-constrictor mechanisms are likely to be involved. Our comparisons 
with naïve rats revealed a significant influence of the dispersion media on vascular tissue 
contractility and fetal weight gain, suggesting MWCNT exposure in isolation has no/
minimal effects under the exposure scenarios applied in this study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ANG II Angiotensin II
ANOVA Analysis of Variance
BAL Bronchoalveolar Lavage
(D)-MWCNTs MWCNT suspended in DPPC and RSA based medium
DPPC1 2-dipalmitoyl-sn-glycero-3-phosphocholine
DPPC/RSA DPPC RSA and Phosphate Buffered Saline-based Medium
GD Gestational Day
EC50 Half-maximal Effective Concentration
Enos Endothelial Nitric Oxide Synthase






MCP1 Monocyte Chemotactic Protein-1
MWCNT Multi-walled Carbon Nanotube
NP Non-pregnant
P Pregnant
PAI1 Plasminogen Activator Inhibitor-1
PE Phenylephrine
PSS Physiological Saline Solution
RAEC Rat Aortic Endothelial Cells
(S)-MWCNTs Multi-walled Carbon Nanotubes dispersed in 10% surfactant
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TNFα Tumor Necrosis Factor, alpha
VEGF Vascular Endothelial Growth Factor
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Figure 1. Changes in the contractile responses of the main uterine artery following intratracheal 
instillation (IT) of MWCNTs
The changes in the contractile responses as assessed by wire myography of the main uterine 
artery from 17 – 19 days pregnant (A, C, E and G) and non-pregnant female (B, D, F and 
H) Sprague Dawley rats, 24 hours following intratracheal instillation of 100 μg/kg of (S)-
MWCNTs or 10% surfactant. The stress generation in response to cumulative concentrations 
of phenylephrine (PE; A and B), angiotensin II (ANG II; C and D) and endothelin 1 (ET-1; 
E and F) are plotted. The percentage relaxation from a 30 μM phenylephrine pre-stimulation 
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stress level in response to cumulative concentrations of acetylcholine (Ach; G and H) is 
graphed. * indicates p < 0.05 compared to 10% surfactant while #indicates p < 0.05 
compared to naïve using repeated measures ANOVA (n = 5 – 7). The p values were derived 
following the comparison of each concentration response curve across treatment groups 
using a regression analysis by examining the best-fit values.
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Figure 2. Changes in the contractile responses of the mesenteric artery following intratracheal 
instillation (IT) of MWCNTs
The changes in the contractile responses were assessed by wire myography of the first order 
mesenteric artery from 17 – 19 days pregnant (A, C, E and G) and non-pregnant female (B, 
D, F and H) Sprague Dawley rats, 24 hours following intratracheal instillation (IT) of 100 
μg/kg of (S)-MWCNTs or 10% surfactant. The stress generation in response to cumulative 
concentrations of phenylephrine (PE; A and B), endothelin 1 (ET-1; C and D) and serotonin 
(5HT; E and F) are plotted. The percentage relaxation from a 30 μM phenylephrine pre-
stimulation stress level in response to cumulative concentrations of acetylcholine (Ach; G 
and H) is graphed. * indicates p < 0.05 compared to 10% surfactant while # indicates p < 
0.05 compared to naïve using repeated measures ANOVA (n = 4 – 7).The p values were 
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derived following the comparison of each concentration response curve across treatment 
groups using a regression analysis by examining the best-fit values.
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Figure 3. Changes in the contractile responses of the thoracic aorta following intratracheal 
instillation (IT) of exposure to MWCNTs
The changes in the contractile responses were assessed by wire myography of the thoracic 
aorta from 17 – 19 days pregnant (A, C and E) and non-pregnant female (B, D and F) 
Sprague Dawley rats, 24 hours following intratracheal instillation of 100 μg/kg of (S)-
MWCNTs or 10% surfactant. The stress generation in response to cumulative concentrations 
of phenylephrine (PE; A and B) and endothelin 1 (ET-1; C and D) are plotted. The 
percentage relaxation form a 10 μM phenylephrine pre-stimulation stress level in response to 
cumulative concentrations of acetylcholine (Ach; E and F) is graphed. * indicates p < 0.05 
compared to 10% surfactant while # indicates p < 0.05 compared to naïve using repeated 
measures ANOVA (n = 4 – 8). The p values were derived following the comparison of each 
concentration response curve across treatment groups using a regression analysis by 
examining the best-fit values.
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Figure 4. Changes in the contractile responses of the main uterine artery following intravenous 
administration (IV) of MWCNTs
The changes in the contractile responses were assessed by wire myography of the main 
uterine artery segments from 17 – 19 days pregnant (A, B, C and D) Sprague Dawley rats, 
24 hours following intravenous administration of 100 μg/kg of (D)-MWCNTs or DPPC/
RSA. The stress generation in response to cumulative concentrations of phenylephrine (PE; 
A), angiotensin II (ANG II; B) and endothelin 1 (ET-1; C) are plotted. The percentage 
relaxation from a 30 μM phenylephrine pre-stimulation stress level in response to cumulative 
concentrations of acetylcholine is graphed (Ach: D). # indicates p < 0.05 compared to naïve 
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using repeated measures ANOVA (n = 5 – 8). The p values were derived following the 
comparison of each concentration response curve across treatment groups using a regression 
analysis by examining the best-fit values.
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Figure 5. Changes in stress generation in the presence of a Rho kinase inhibitor following 
intratracheal instillation (IT) MWCNTs
The reduction in stress generation is reported as the percentage relaxation from a 
phenylephrine (30 μM for uterine/mesenteric arteries and 10 μM for aorta) pre-stimulation 
stress level in response to cumulative additions of a Rho kinase inhibitor (HA1077). All 
responses were assessed by wire myography, 24 hours following intratracheal instillation of 
100 μg/kg of (S)-MWCNTs or 10% surfactant from 17 – 19 days pregnant (A, C and E) and 
non-pregnant female (B, D and F) Sprague Dawley rats. Panels A and B: main uterine 
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artery; C and D: first order mesenteric artery; E and F: thoracic aorta. # indicates p < 0.05 
compared to naïve using repeated measures ANOVA (n = 4 – 6). The p values were derived 
following the comparison of each concentration response curve across treatment groups 
using a regression analysis by examining the best-fit values.
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Figure 6. Changes in contractile responses of the umbilical vein following maternal exposure to 
MWCNTs
The changes stress generation in the umbilical vein segments were assessed by wire 
myography in response to 109 mM K+ depolarization (A and B) and 1 μM thromboxane 
agonist (U46619, B and D) 24 hours post-exposure to intratracheal instillation (IT) of 100 
μg/kg of (S)-MWCNTs or 10% surfactant (A and C) or intravenous administration (IV) of 
(D)-MWCNTs or DPPC/RSA (B and D), from 17 – 19 days pregnant Sprague Dawley rats 
(n = 12). The percentage relaxation in response to sodium nitroprusside (SNP) following 
U46619 (1 μM) pre-contraction in the umbilical vein 24 hours post-exposure to intratracheal 
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instillation of (S)-MWCNTs or 10% surfactant (E) or intravenous administration of (D)-
MWCNT or DPPC/RSA is graphed (F) (n = 12).
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Figure 7. Changes in the fetal and placental weight following exposure to MWCNTs
Changes in fetal (A and B) and placental (C and D) weight 24 hours post-exposure to 
intratracheal instillation (IT) of 100 μg/kg of (S)-MWCNTs or 10% surfactant (A and C) or 
intravenous administration (IV) of (D)-MWCNTs or DPPC/RSA (B and D) in 17 – 19 days 
pregnant Sprague Dawley rats. Three pups/placentae were weighed from each dam included 
in the study and the number of pups/placentae are indicated within each bar. * indicates p < 
0.05 when compared using one way ANOVA and Turkey post-hoc test. GD = day of 
gestation
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